BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22822039)

  • 1. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.
    Sashindranath M; Sales E; Daglas M; Freeman R; Samson AL; Cops EJ; Beckham S; Galle A; McLean C; Morganti-Kossmann C; Rosenfeld JV; Madani R; Vassalli JD; Su EJ; Lawrence DA; Medcalf RL
    Brain; 2012 Nov; 135(Pt 11):3251-64. PubMed ID: 22822039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns.
    Yang D; Nemkul N; Shereen A; Jone A; Dunn RS; Lawrence DA; Lindquist D; Kuan CY
    J Neurosci; 2009 Jul; 29(27):8669-74. PubMed ID: 19587273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
    Yepes M; Sandkvist M; Moore EG; Bugge TH; Strickland DK; Lawrence DA
    J Clin Invest; 2003 Nov; 112(10):1533-40. PubMed ID: 14617754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system.
    Yepes M; Lawrence DA
    Exp Biol Med (Maywood); 2004 Dec; 229(11):1097-104. PubMed ID: 15564435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain.
    Fabbro S; Seeds NW
    J Neurochem; 2009 Apr; 109(2):303-15. PubMed ID: 19222708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.
    Pepper MS
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1104-17. PubMed ID: 11451738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase.
    Rakkar K; Srivastava K; Bayraktutan U
    Eur J Neurosci; 2014 Jun; 39(12):2119-28. PubMed ID: 24649947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
    Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
    J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.
    Adibhatla RM; Hatcher JF
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):243-53. PubMed ID: 18673209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
    Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
    Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
    Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
    Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
    J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells.
    Rossignol P; Ho-Tin-Noé B; Vranckx R; Bouton MC; Meilhac O; Lijnen HR; Guillin MC; Michel JB; Anglés-Cano E
    J Biol Chem; 2004 Mar; 279(11):10346-56. PubMed ID: 14699093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin D-like aspartyl protease activity mediates the degradation of tissue-type plasminogen activator/plasminogen activator inhibitor-1 complexes in human monocytes.
    Simon DI; Xu H; Vaughan DE
    Biochim Biophys Acta; 1995 Aug; 1268(2):143-51. PubMed ID: 7662701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes.
    Makarova A; Mikhailenko I; Bugge TH; List K; Lawrence DA; Strickland DK
    J Biol Chem; 2003 Dec; 278(50):50250-8. PubMed ID: 14522960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
    Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
    J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
    Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
    Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse.
    Krueger SR; Ghisu GP; Cinelli P; Gschwend TP; Osterwalder T; Wolfer DP; Sonderegger P
    J Neurosci; 1997 Dec; 17(23):8984-96. PubMed ID: 9364046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.